66
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Neutrophil-to-Lymphocyte Ratio Can Distinguish Patients with Liver Cirrhosis from Healthy People but Cannot Distinguish Patients with Cirrhotic Hepatocellular Carcinoma from Patients with Liver Cirrhosis

ORCID Icon & ORCID Icon
Pages 1127-1136 | Received 29 Aug 2022, Accepted 15 Oct 2022, Published online: 29 Oct 2022

References

  • Chen FH, Wang JM, Wu YC, Gao Q, Zhang S. Potential biomarkers for liver cancer diagnosis based on multi-omics strategy. Front Oncol. 2022;12:822449. doi:10.3389/fonc.2022.822449
  • de Mattos ÂZ, Debes JD, Boonstra A, et al. Current impact of viral hepatitis on liver cancer development: the challenge remains. World J Gastroenterol. 2021;27(24):3556–3567. doi:10.3748/wjg.v27.i24.3556
  • Chen JG, Zhu J, Zhang YH, et al. Liver cancer survival: a real world observation of 45 years with 32,556 Cases. J Hepatocell Carcinoma. 2021;8:1023–1034. doi:10.2147/JHC.S321346
  • Moreno-Gonzalez M, Beraza N. The role of the microbiome in liver cancer. Cancers. 2021;13(10):2330. doi:10.3390/cancers13102330
  • Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398(10308):1359–1376. doi:10.1016/S0140-6736(21)
  • Kaplan A, Rosenblatt R. Symptom management in patients with cirrhosis: a practical guide. Curr Treat Options Gastroenterol. 2022;17:1–16. doi:10.1007/s11938-022-00377-y
  • Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379(9822):1245–1255. doi:10.1016/S0140-6736(11)
  • Du ZQ, Dong J, Bi JB, et al. Predictive value of the preoperative neutrophil-to-lymphocyte ratio for the development of hepatocellular carcinoma in HBV-associated cirrhotic patients after splenectomy. PLoS One. 2018;13(4):e0195336. doi:10.1371/journal.pone.0195336
  • Liu Y, Wu H, Mei Y, et al. Clinicopathological and prognostic significance of PKM2 protein expression in cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma. Sci Rep. 2017;7(1):15294. doi:10.1038/s41598-017-14813-y
  • Caviglia GP, Ciruolo M, Abate ML, et al. Alpha-fetoprotein, protein induced by vitamin K absence or antagonist II and glypican-3 for the detection and prediction of hepatocellular carcinoma in patients with cirrhosis of viral etiology. Cancers. 2020;12(11):3218. doi:10.3390/cancers12113218
  • Hu J, Wang NY, Yang YF, et al. Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma. BMC Gastroenterol. 2018;18(1):186. doi:10.1186/s12876-018-0908-6
  • Mantovani A, Barajon I, Garlanda C. IL-1 and IL-1 regulatory pathways in cancer progression and therapy. Immunol Rev. 2018;281(1):57–61. doi:10.1111/imr.12614
  • Pease NA, Wise-Draper T, Privette Vinnedge L. Dissecting the potential interplay of DEK functions in inflammation and cancer. J Oncol. 2015;2015:106517. doi:10.1155/2015/106517
  • Soder HE, Berumen AM, Gomez KE, et al. Elevated neutrophil to lymphocyte ratio in older adults with cocaine use disorder as a marker of chronic inflammation. Clin Psychopharmacol Neurosci. 2020;18(1):32–40. doi:10.9758/cpn.2020.18.1.32
  • Chen LF, Wang XY, Shu J, Xu S, Wu Q, Yu Y. Diagnostic value of serum D-dimer, CA125, and neutrophil-to-lymphocyte ratio in differentiating ovarian cancer and endometriosis. Int J Gynaecol Obstet. 2019;147(2):212–218. doi:10.1002/ijgo.12949
  • Adhyatma KP, Prapiska FF, Siregar GP, Warli SM. Systemic inflammatory response in predicting prostate cancer: the diagnostic value of neutrophil-to-lymphocyte ratio. Open Access Maced J Med Sci. 2019;7(10):1628–1630. doi:10.3889/oamjms.2019.177
  • Liu J, Li H, Xia J, et al. Baseline neutrophil-to-lymphocyte ratio is independently associated with 90-day transplant free mortality in patients with cirrhosis. Front Med. 2021;8:726950. doi:10.3389/fmed.2021.726950
  • Popoiag RE, Suceveanu AI, Suceveanu AP, et al. Predictors of spontaneous bacterial peritonitis in Romanian adults with liver cirrhosis: focus on the neutrophil-to-lymphocyte ratio. Exp Ther Med. 2021;22(3):983. doi:10.3892/etm.2021.10415
  • Rau CS, Wu SC, Tsai CH, et al. Association of white blood cell subtypes and derived ratios with a mortality outcome in adult patients with polytrauma. Healthcare. 2022;10(8):1384. doi:10.3390/healthcare10081384
  • Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-The ALBI grade. J Clin Oncol. 2015;33(6):550–558. doi:10.1200/JCO.2014.57.9151
  • Asrani SK, Kim WR. Clinical applications of the model for end-stage liver disease (MELD) in hepatic medicine. Clin Liver Dis. 2011;15(4):685–698. doi:10.1016/j.cld.2011.08.009
  • Li CX, Wang HW, Chen RX, et al. Outcomes and recurrence patterns following curative hepatectomy for hepatocellular carcinoma patients with different China liver cancer staging. Am J Cancer Res. 2022;12(2):907–921.
  • McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2021;73(Suppl 1):4–13. doi:10.1002/hep.31288
  • Li Y, Wang J, Wang HY, Zhang SQ, Wei YX, Liu SL. The interplay between inflammation and stromal components in pancreatic cancer. Front Immunol. 2022;13:850093. doi:10.3389/fimmu.2022.850093
  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi:10.1016/j.cell.2011.02.013
  • Guerville F, Bourdel-Marchasson I, Déchanet-Merville J, et al. Does inflammation contribute to cancer incidence and mortality during aging? A Conceptual Review. Cancers. 2022;14(7):1622. doi:10.3390/cancers14071622
  • Paliogiannis P, Fois AG, Sotgia S, et al. Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives. Eur Respir Rev. 2018;27(147):17011322. doi:10.1183/16000617.0113-2017
  • Yamada S, Kaneshiro T, Yoshihisa A, et al. Albumin-bilirubin score for prediction of outcomes in heart failure patients treated with cardiac resynchronization therapy. J Clin Med. 2021;10(22):5378. doi:10.3390/jcm10225378
  • Han S, Wang CH, Tong F, et al. Prognostic impact of albumin-bilirubin score on the prediction of in-hospital mortality in patients with heart failure: a retrospective cohort study. BMJ OPEN. 2022;12(1):e049325. doi:10.1136/bmjopen-2021-049325
  • Takada K, Takamori S, Shimokawa M, et al. Assessment of the albumin-bilirubin grade as a prognostic factor in patients with non-small-cell lung cancer receiving anti-PD-1-based therapy. ESMO Open. 2022;7(1):100348. doi:10.1016/j.esmoop.2021.100348
  • Caraceni P, Riggio O, Angeli P, et al. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. Lancet. 2018;391(10138):2417–2429. doi:10.1016/S0140-6736(18)
  • Chen L, Lou Y, Chen Y, Yang J. Prognostic value of the neutrophil-to-lymphocyte ratio in patients with acute-on-chronic liver failure. Int J Clin Pract. 2014;68(8):1034–1040. doi:10.1111/ijcp.12408
  • Ma LN, Liu XY, Lu ZH, et al. Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis. Oncol Lett. 2017;13(5):3457–3464. doi:10.3892/ol.2017.5890